Skip to main content

Table 3 Meta-analyses of miR-140 expression classified by clinicopathological parameters

From: Prognostic and clinicopathological importance of microRNA-140 expression in cancer patients: a meta-analysis

Study covariates

Studies (patients)

OR (95% CI)

I2 (%)

Ph

Z

P

Model

Gender (male/female)

7 (770)

1.068 (0.761-1.499)

30.0

0.199

0.38

0.703

Fixed

Age (< 60/≥ 60)

3 (257)

0.859 (0.500-1.475)

0.0

0.519

0.55

0.582

Fixed

Tumor size (≤ 5/> 5 cm)

3 (257)

1.152 (0.352-3.773)

79.0

0.008

0.23

0.815

Random

TNM stage (1-2/3-4)

6 (614)

0.420 (0.299-0.590)

43.4

0.113

5.00

< 0.001

Fixed

LN metastasis (absence/presence)

6 (568)

0.341 (0.144-0.807)

78.9

< 0.001

2.45

0.014

Random

Histologic grade (well+ moderately differentiated/ poorly differentiated)

4 (389)

0.410 (0.261-0.643)

0.0

0.552

3.88

< 0.001

Fixed

  1. LN lymph node, OR odds ratio, CI confidence intervals, Ph P value for heterogeneity based on Q test, P P value for statistical significance based on Z test